Loading...

Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical data sheet

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References

(PubMed link indicates BioLegend citation)
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  2. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  3. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  4. Kim S, et al. 2020. Development. 147:00:00. PubMed
  5. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  6. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  7. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  8. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  9. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  10. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  11. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  12. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  13. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  14. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  15. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  16. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  17. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  18. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  19. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  20. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  21. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  22. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  23. Poli V, et al. 2021. iScience. 24:103256. PubMed
  24. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  25. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  26. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  27. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  28. Stewart CA, et al. 2020. bioRxiv. . PubMed
  29. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  30. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  31. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  32. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  33. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  34. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  35. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  36. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  37. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  38. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  39. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  40. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  41. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  42. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  43. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  44. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  45. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  46. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  47. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  48. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  49. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  50. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  51. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  52. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  53. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  54. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  55. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  56. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  57. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  58. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  59. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  60. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  61. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  62. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  63. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  64. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  65. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  66. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  67. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  68. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  69. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  70. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  71. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  72. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  73. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  74. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  75. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  76. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  77. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  78. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  79. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  80. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  81. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  82. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  83. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  84. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  85. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  86. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  87. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  88. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  89. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  90. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  91. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  92. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  93. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  94. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  95. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  96. Kim S, et al. 2020. Development. . PubMed
  97. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  98. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  99. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  100. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  101. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  102. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  103. Ma K, et al. 2022. iScience. 25:104347. PubMed
  104. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  105. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  106. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  107. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  108. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  109. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  110. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  111. Lau H, et al. 2020. Islets. 41:12. PubMed
  112. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  113. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  114. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  115. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  116. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  117. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  118. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  119. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  120. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  121. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  122. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  123. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  124. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  125. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  126. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  127. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  128. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  129. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  130. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  131. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  132. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  133. Lee G, et al. 2021. Viruses. 13: . PubMed
  134. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  135. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  136. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  137. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  138. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  139. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  140. Su Y, et al. 2020. Cell. 1479:183. PubMed
  141. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  142. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  143. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  144. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  145. Wang X, et al. 2022. Elife. 11:. PubMed
  146. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  147. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  148. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  149. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  150. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  151. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  152. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  153. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  154. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  155. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  156. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  157. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  158. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  159. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  160. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08.26.2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account